Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line

Authors: Huan Gu, Xianquan Zhan, Guiying Zhang, Lu Yan, William CS Cho, Maoyu Li, Ting Liu, Zhuchu Chen

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

Gastric cancer (GC) is a threat to human health with increasing incidence and mortality worldwide. Down-regulation or absence of RAF kinase inhibitor protein (RKIP) was associated with the occurrence, differentiation, invasion, and metastasis of GC. This study aims to investigate the molecular mechanisms and biological functions of RKIP in the GC biology.

Methods

The fusion expression plasmid pcDNA3.1-RKIP-3xFLAG was transfected into SGC7901 cells, the RKIP fusion proteins were purified with anti-flag M2 magnetic beads, and the RKIP-interacting proteins were identified with tandem mass spectrometry (MS/MS), and were analyzed with bioinformatics tools. Western blot and co-immunoprecipitation were used to confirm the interaction complex.

Results

A total of 72 RKIP-interacting proteins were identified by MS/MS. Those proteins play roles in enzyme metabolism, molecular chaperoning, biological oxidation, cytoskeleton organization, signal transduction, and enzymolysis. Three RKIP-interaction protein network diagrams were constructed with Michigan Molecular Interactions, functional linage network, and Predictome analysis to address the molecular pathways of the functional activity of RKIP. The MS/MS-characterized components of the existing interaction complex (RKIP, HSP90, 14-3-3ϵ, and keratin 8) were confirmed by Western blot analysis and co-immunoprecipitation.

Conclusion

This study is the first discovery of the interaction of RKIP with HSP90, 14-3-3, and keratin. The present data would provide insight into the molecular mechanisms of how RKIP inhibits the occurrence and development of GC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Katherine DC, Alfred IN: Epidemiology of gastric cancer. World J Gastroenterol. 2006, 12: 354-362.CrossRef Katherine DC, Alfred IN: Epidemiology of gastric cancer. World J Gastroenterol. 2006, 12: 354-362.CrossRef
2.
go back to reference Fox JG, Wang TC: Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007, 117: 0-9.CrossRef Fox JG, Wang TC: Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007, 117: 0-9.CrossRef
3.
go back to reference Zhang ZQ, Li MY, Zhang GY, Peng F, Yao HX, Xiao ZQ, Chen ZC: Identification of human gastric carcinoma biomarkers by differential protein expression analysis using 18O labeling and NanoLC-MS/MS coupled with laser capture microdissection. Med Oncol. 2010, 27: 296-303. 10.1007/s12032-009-9208-x.CrossRefPubMed Zhang ZQ, Li MY, Zhang GY, Peng F, Yao HX, Xiao ZQ, Chen ZC: Identification of human gastric carcinoma biomarkers by differential protein expression analysis using 18O labeling and NanoLC-MS/MS coupled with laser capture microdissection. Med Oncol. 2010, 27: 296-303. 10.1007/s12032-009-9208-x.CrossRefPubMed
4.
go back to reference Jia BQ, Liu H, Kong Q, Li B: RKIP expression associated with gastric cancer cell invasion and metastasis. Tumor Biol. 2012, doi:10.1007/s13277-012-0317-3 Jia BQ, Liu H, Kong Q, Li B: RKIP expression associated with gastric cancer cell invasion and metastasis. Tumor Biol. 2012, doi:10.1007/s13277-012-0317-3
5.
go back to reference Trakul N, Rosner MR: Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 2005, 15: 19-23. 10.1038/sj.cr.7290258.CrossRefPubMed Trakul N, Rosner MR: Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 2005, 15: 19-23. 10.1038/sj.cr.7290258.CrossRefPubMed
6.
go back to reference Zhang ZQ, Zhang GY, Li MY, Liu T: Expression of Raf kinase inhibitor protein in human gastric cancer and its clinical significance. Chin J Dig. 2009, 5: 312-316. Zhang ZQ, Zhang GY, Li MY, Liu T: Expression of Raf kinase inhibitor protein in human gastric cancer and its clinical significance. Chin J Dig. 2009, 5: 312-316.
7.
go back to reference Fu Z, Smith PC, Zhang LZ, Rubin MA, Dunn RL, Yao Z, Keller ET: Effects of Raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003, 95: 878-889. 10.1093/jnci/95.12.878.CrossRefPubMed Fu Z, Smith PC, Zhang LZ, Rubin MA, Dunn RL, Yao Z, Keller ET: Effects of Raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003, 95: 878-889. 10.1093/jnci/95.12.878.CrossRefPubMed
8.
go back to reference Keller ET, Brennan M: The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. J Cell Biochem. 2005, 94: 273-278. 10.1002/jcb.20169.CrossRefPubMed Keller ET, Brennan M: The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. J Cell Biochem. 2005, 94: 273-278. 10.1002/jcb.20169.CrossRefPubMed
9.
go back to reference Keller ET: Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer. Immunopathol Dis Therap. 2011, 2: 89-94. Keller ET: Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer. Immunopathol Dis Therap. 2011, 2: 89-94.
10.
go back to reference Dabbous MK, Jefferson MM, Haney L, Thomas EL: Biomarkers of metastatic potential in cultured adenocarcinoma clones. Clin Exp Metastasis. 2011, 28: 101-111. 10.1007/s10585-010-9362-8.CrossRefPubMed Dabbous MK, Jefferson MM, Haney L, Thomas EL: Biomarkers of metastatic potential in cultured adenocarcinoma clones. Clin Exp Metastasis. 2011, 28: 101-111. 10.1007/s10585-010-9362-8.CrossRefPubMed
11.
go back to reference Schuierer MM, Heilmeier U, Boettcher A, Ugocsai P, Bosserhoff AK, Schmitz G, Langmann T: Induction of Raf kinase inhibitor protein contributes to macrophage differentiation. Biochem Biophys Res Commun. 2006, 342: 1083-1087. 10.1016/j.bbrc.2006.02.083.CrossRefPubMed Schuierer MM, Heilmeier U, Boettcher A, Ugocsai P, Bosserhoff AK, Schmitz G, Langmann T: Induction of Raf kinase inhibitor protein contributes to macrophage differentiation. Biochem Biophys Res Commun. 2006, 342: 1083-1087. 10.1016/j.bbrc.2006.02.083.CrossRefPubMed
12.
go back to reference Park S, Yeung ML, Beach S, Shields JM, Yeung KC: RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene. 2005, 24: 3535-3540. 10.1038/sj.onc.1208435.CrossRefPubMed Park S, Yeung ML, Beach S, Shields JM, Yeung KC: RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene. 2005, 24: 3535-3540. 10.1038/sj.onc.1208435.CrossRefPubMed
13.
go back to reference Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A: Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res. 2008, 14: 143-148. 10.1158/1078-0432.CCR-07-1380.CrossRefPubMed Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L, Lugli A: Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res. 2008, 14: 143-148. 10.1158/1078-0432.CCR-07-1380.CrossRefPubMed
14.
go back to reference Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G: Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion at the level of matrix metalloproteinase expression but not cell migration. Cancer Lett. 2010, 299: 137-149. 10.1016/j.canlet.2010.08.012.CrossRefPubMedPubMedCentral Beshir AB, Ren G, Magpusao AN, Barone LM, Yeung KC, Fenteany G: Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion at the level of matrix metalloproteinase expression but not cell migration. Cancer Lett. 2010, 299: 137-149. 10.1016/j.canlet.2010.08.012.CrossRefPubMedPubMedCentral
15.
go back to reference Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Garcia C, Kolch W: Reduction of Raf-1 kinase inhibitor protein expression correlates with bread cancermetastasis. Clin Cancer Res. 2005, 11: 7392-3797. 10.1158/1078-0432.CCR-05-0283.CrossRefPubMed Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, Garcia C, Kolch W: Reduction of Raf-1 kinase inhibitor protein expression correlates with bread cancermetastasis. Clin Cancer Res. 2005, 11: 7392-3797. 10.1158/1078-0432.CCR-05-0283.CrossRefPubMed
16.
go back to reference Beshir AB, Argueta CE, Menikarachchi LC, Gascon JA, Genteany G: Locostatin disrupts association of Raf kinase inhibitor protein with binding proteins by modifying a conserved histidine residue in the ligand-binding pocket. Immunopathol Dis Therap. 2011, 2: 47-58. Beshir AB, Argueta CE, Menikarachchi LC, Gascon JA, Genteany G: Locostatin disrupts association of Raf kinase inhibitor protein with binding proteins by modifying a conserved histidine residue in the ligand-binding pocket. Immunopathol Dis Therap. 2011, 2: 47-58.
17.
go back to reference Tavel L, Jaquillard L, Karsisiotis AI, Saab F, Jouvensal L, Brans A, Delmas AF, Schoentgen F, Cadene M, Damblon C: Ligand binding study of human PEBP1/RKIP: Interaction with nucleotides and Raf-1 peptides evidenced by NMR and mass spectrometry. PLoS One. 2012, 7: e36187-10.1371/journal.pone.0036187.CrossRefPubMedPubMedCentral Tavel L, Jaquillard L, Karsisiotis AI, Saab F, Jouvensal L, Brans A, Delmas AF, Schoentgen F, Cadene M, Damblon C: Ligand binding study of human PEBP1/RKIP: Interaction with nucleotides and Raf-1 peptides evidenced by NMR and mass spectrometry. PLoS One. 2012, 7: e36187-10.1371/journal.pone.0036187.CrossRefPubMedPubMedCentral
19.
go back to reference Ueda M, Manabe Y, Mukai M: The high performance of 3XFLAG for target purification of a bioactive metabolite: a tag combined with a highly effective linker structure. Bioorganic Med Chem Lett. 2011, 21: 1359-1362. 10.1016/j.bmcl.2011.01.038.CrossRef Ueda M, Manabe Y, Mukai M: The high performance of 3XFLAG for target purification of a bioactive metabolite: a tag combined with a highly effective linker structure. Bioorganic Med Chem Lett. 2011, 21: 1359-1362. 10.1016/j.bmcl.2011.01.038.CrossRef
20.
go back to reference Zheng S, Ghitani N, Blackburn JS, Liu JP, Zeitlin SO: A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal huntingtin’s polyglutamine stretch on CAG140 mouse model pathogenesis. Mol Brain. 2012, 5: 28-10.1186/1756-6606-5-28.CrossRefPubMedPubMedCentral Zheng S, Ghitani N, Blackburn JS, Liu JP, Zeitlin SO: A series of N-terminal epitope tagged Hdh knock-in alleles expressing normal and mutant huntingtin: their application to understanding the effect of increasing the length of normal huntingtin’s polyglutamine stretch on CAG140 mouse model pathogenesis. Mol Brain. 2012, 5: 28-10.1186/1756-6606-5-28.CrossRefPubMedPubMedCentral
21.
go back to reference Macleod G, Varmuza S: Tandem affinity purification in transgenic mouse embryonic stem cells identifies DDOST as a novel PPP1CC2 interacting protein. Biochemistry. 2012, in press Macleod G, Varmuza S: Tandem affinity purification in transgenic mouse embryonic stem cells identifies DDOST as a novel PPP1CC2 interacting protein. Biochemistry. 2012, in press
22.
go back to reference Qu Y, Misaghi S, Izrael-Tomasevic A, Newton K, Gilmour LL, Lamkanfi M, Louie S, Kayagaki N, Liu J, Kömüves L, Cupp JE, Arnott D, Monack D, Dixit VM: Phosphorylation of NLRC4 is critical for inflammasome activation. Nature. 2012, 490: 539-542. 10.1038/nature11429.CrossRefPubMed Qu Y, Misaghi S, Izrael-Tomasevic A, Newton K, Gilmour LL, Lamkanfi M, Louie S, Kayagaki N, Liu J, Kömüves L, Cupp JE, Arnott D, Monack D, Dixit VM: Phosphorylation of NLRC4 is critical for inflammasome activation. Nature. 2012, 490: 539-542. 10.1038/nature11429.CrossRefPubMed
23.
go back to reference Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, Kirkpatrick DS, Pham VC, Lill JR, Bakalarski CE, Wu J, Phu L, Katavolos P, LaFave LM, Abdel-Wahab O, Modrusan Z, Seshagiri S, Dong K, Lin Z, Balazs M, Suriben R, Newton K, Hymowitz S, Garcia-Manero G, Martin F, Levine RL, Dixit VM: Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012, 337: 1541-1546. 10.1126/science.1221711.CrossRefPubMed Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, Kirkpatrick DS, Pham VC, Lill JR, Bakalarski CE, Wu J, Phu L, Katavolos P, LaFave LM, Abdel-Wahab O, Modrusan Z, Seshagiri S, Dong K, Lin Z, Balazs M, Suriben R, Newton K, Hymowitz S, Garcia-Manero G, Martin F, Levine RL, Dixit VM: Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012, 337: 1541-1546. 10.1126/science.1221711.CrossRefPubMed
24.
go back to reference Lee H, Park M, Shin N, Kim G, Kim YG, Shin JS, Kim H: High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem Biophys Res Commun. 2012, 424: 321-326. 10.1016/j.bbrc.2012.06.116.CrossRefPubMed Lee H, Park M, Shin N, Kim G, Kim YG, Shin JS, Kim H: High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells. Biochem Biophys Res Commun. 2012, 424: 321-326. 10.1016/j.bbrc.2012.06.116.CrossRefPubMed
25.
go back to reference Aichem A, Groettrup M: Detection and analysis of FAT10 modification. Methods Mol Biol. 2012, 832: 125-132. 10.1007/978-1-61779-474-2_7.CrossRefPubMed Aichem A, Groettrup M: Detection and analysis of FAT10 modification. Methods Mol Biol. 2012, 832: 125-132. 10.1007/978-1-61779-474-2_7.CrossRefPubMed
26.
go back to reference Cardenal-Muñoz E, Ramos-Morales F: Analysis of the expression, secretion and translocation of the Salmonella enterica type III secretion system effector SteA. PLoS One. 2011, 6: e26930-10.1371/journal.pone.0026930.CrossRefPubMedPubMedCentral Cardenal-Muñoz E, Ramos-Morales F: Analysis of the expression, secretion and translocation of the Salmonella enterica type III secretion system effector SteA. PLoS One. 2011, 6: e26930-10.1371/journal.pone.0026930.CrossRefPubMedPubMedCentral
27.
go back to reference Adlard PA, Bush AL: Metals and Alzheimer’s disease. J ALzheimers Dis. 2006, 10: 145-163.PubMed Adlard PA, Bush AL: Metals and Alzheimer’s disease. J ALzheimers Dis. 2006, 10: 145-163.PubMed
28.
go back to reference Nichols A, Camps M, Gillieron C, Chabert C, Brunet A, Wilsbacher J, Cobb M, Pouyssegur J, Shaw JP, Arkinstall S: Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3. J Biol Chem. 2000, 275: 24613-24621. 10.1074/jbc.M001515200.CrossRefPubMed Nichols A, Camps M, Gillieron C, Chabert C, Brunet A, Wilsbacher J, Cobb M, Pouyssegur J, Shaw JP, Arkinstall S: Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3. J Biol Chem. 2000, 275: 24613-24621. 10.1074/jbc.M001515200.CrossRefPubMed
29.
go back to reference Liang SL, He LJ, Zhao XD, Miao Y, Gu Y, Guo CC, Xue ZF, Dou WJ, Hu FR, Wu KC, Nie YZ, Fan DM: MicroRNA Let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One. 2011, 6: e18409-10.1371/journal.pone.0018409.CrossRefPubMedPubMedCentral Liang SL, He LJ, Zhao XD, Miao Y, Gu Y, Guo CC, Xue ZF, Dou WJ, Hu FR, Wu KC, Nie YZ, Fan DM: MicroRNA Let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PLoS One. 2011, 6: e18409-10.1371/journal.pone.0018409.CrossRefPubMedPubMedCentral
30.
go back to reference Walch A, Seidl S, Hermannstadter C: Combined analysis of Racl, IQGAP, Tiaml and E-cadherin expression in gastric cancer. Mod Pathol. 2008, 21: 544-552. 10.1038/modpathol.2008.3.CrossRefPubMed Walch A, Seidl S, Hermannstadter C: Combined analysis of Racl, IQGAP, Tiaml and E-cadherin expression in gastric cancer. Mod Pathol. 2008, 21: 544-552. 10.1038/modpathol.2008.3.CrossRefPubMed
31.
go back to reference Yu GZ, Wang JJ, Chen Y, Wang X, Pan J, Li Q, Xie KP: Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis. 2008, 25: 695-702. 10.1007/s10585-008-9178-y.CrossRefPubMed Yu GZ, Wang JJ, Chen Y, Wang X, Pan J, Li Q, Xie KP: Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis. 2008, 25: 695-702. 10.1007/s10585-008-9178-y.CrossRefPubMed
32.
go back to reference Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, Lin KH: Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics. 2007, 7: 155-167. 10.1002/pmic.200600663.CrossRefPubMed Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, Lin KH: Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics. 2007, 7: 155-167. 10.1002/pmic.200600663.CrossRefPubMed
33.
go back to reference Zhang Y, Qu X, Jing W, Hu X, Yang X, Teng K, Zhang J, Liu Y: GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cell: regulation by promoter methylation and extracellular regulated kinase signaling. Anticancer Drugs. 2009, 20: 208-214. 10.1097/CAD.0b013e328322fbaa.CrossRefPubMed Zhang Y, Qu X, Jing W, Hu X, Yang X, Teng K, Zhang J, Liu Y: GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cell: regulation by promoter methylation and extracellular regulated kinase signaling. Anticancer Drugs. 2009, 20: 208-214. 10.1097/CAD.0b013e328322fbaa.CrossRefPubMed
34.
go back to reference Yu X, Guo ZS, Marcu MG, Neckers L, Nguyen DM, Chen GA, Schrump DS: Modulation of p53, ERbB1, ERbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J Nat Cancer Inst. 2002, 94: 504-513. 10.1093/jnci/94.7.504.CrossRefPubMed Yu X, Guo ZS, Marcu MG, Neckers L, Nguyen DM, Chen GA, Schrump DS: Modulation of p53, ERbB1, ERbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J Nat Cancer Inst. 2002, 94: 504-513. 10.1093/jnci/94.7.504.CrossRefPubMed
35.
go back to reference Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Ann Rev Pharmacol Toxicol. 2000, 40: 617-647. 10.1146/annurev.pharmtox.40.1.617.CrossRef Fu H, Subramanian RR, Masters SC: 14-3-3 proteins: structure, function, and regulation. Ann Rev Pharmacol Toxicol. 2000, 40: 617-647. 10.1146/annurev.pharmtox.40.1.617.CrossRef
36.
go back to reference Liu X, Ye L, Wang J, Fan D: Expression of heat shock protein 90 in human gastric cancer tissue and SGC7901/VCR of MDR-type gastric cancer cell line. Chin Med J. 1999, 112: 1133-1137.PubMed Liu X, Ye L, Wang J, Fan D: Expression of heat shock protein 90 in human gastric cancer tissue and SGC7901/VCR of MDR-type gastric cancer cell line. Chin Med J. 1999, 112: 1133-1137.PubMed
37.
go back to reference Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, Yashiro M, Hirakawa K, Oka M, Nakamura K: Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells. Anticancer Res. 2010, 30: 4459-4465.PubMed Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, Yashiro M, Hirakawa K, Oka M, Nakamura K: Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells. Anticancer Res. 2010, 30: 4459-4465.PubMed
38.
go back to reference Jaqietto E, Krasnowska M: The role of genetic factors, apoptosis and 14-3-3 protein in induction of atopic diseases. Postepy Hiq Med Dosw. 1997, 51: 385-398. Jaqietto E, Krasnowska M: The role of genetic factors, apoptosis and 14-3-3 protein in induction of atopic diseases. Postepy Hiq Med Dosw. 1997, 51: 385-398.
39.
go back to reference Thorson JA, Yu LW, Hsu AL, Shih NY, Graves PR, Tanner JW, Allen PM, Piwnica-Worms H, Shawl AS: 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol. 1998, 8: 529-538. Thorson JA, Yu LW, Hsu AL, Shih NY, Graves PR, Tanner JW, Allen PM, Piwnica-Worms H, Shawl AS: 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol. 1998, 8: 529-538.
40.
go back to reference Zuo S, Xue Y, Tang SW, Yao J, Du D, Yang P, Chen X: 14-3-3 epsilon dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-α-induced time course-dependent NF-γB activity. J Proteome Res. 2010, 9: 3465-3478. 10.1021/pr9011377.CrossRefPubMed Zuo S, Xue Y, Tang SW, Yao J, Du D, Yang P, Chen X: 14-3-3 epsilon dynamically interacts with key components of mitogen-activated protein kinase signal module for selective modulation of the TNF-α-induced time course-dependent NF-γB activity. J Proteome Res. 2010, 9: 3465-3478. 10.1021/pr9011377.CrossRefPubMed
41.
go back to reference Liang S, Xu Y, Shen G, Liu Q, Zhao X, Xu Z, Xie X, Gong F, Li F, Li R, Wei Y: Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly renal cell proliferation. Electrophoresis. 2009, 30: 4152-4162. 10.1002/elps.200900249.CrossRefPubMed Liang S, Xu Y, Shen G, Liu Q, Zhao X, Xu Z, Xie X, Gong F, Li F, Li R, Wei Y: Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly renal cell proliferation. Electrophoresis. 2009, 30: 4152-4162. 10.1002/elps.200900249.CrossRefPubMed
42.
go back to reference Liu Y, Song F, Wu WKK, He M, Zhao L, Sun X, Li H, Jiang Y, Yang Y, Peng K: Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon. Cell Biochem Funct. 2012, doi:10.1002/cbf.2793 Liu Y, Song F, Wu WKK, He M, Zhao L, Sun X, Li H, Jiang Y, Yang Y, Peng K: Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon. Cell Biochem Funct. 2012, doi:10.1002/cbf.2793
Metadata
Title
Mapping the interactome of overexpressed RAF kinase inhibitor protein in a gastric cancer cell line
Authors
Huan Gu
Xianquan Zhan
Guiying Zhang
Lu Yan
William CS Cho
Maoyu Li
Ting Liu
Zhuchu Chen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-536

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine